Literature DB >> 24855709

Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule.

.   

Abstract

The final rule will revise the Medicare Advantage (MA) program (Part C) regulations and prescription drug benefit program (Part D) regulations to implement statutory requirements; improve program efficiencies; and clarify program requirements. The final rule also includes several provisions designed to improve payment accuracy.

Mesh：

Year:  2014        PMID： 24855709

Source DB:  PubMed          Journal:  Fed Regist        ISSN： 0097-6326


  18 in total

1.  Trends in Medicare Part D Medication Therapy Management Eligibility Criteria.

Authors:  Junling Wang; Ya-Chen Tina Shih; Yolanda Qin; Theo Young; Zachary Thomas; Christina A Spivey; David K Solomon; Marie Chisholm-Burns
Journal:  Am Health Drug Benefits       Date:  2015 Jul-Aug

2.  Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.

Authors:  Christina A Spivey; Yanru Qiao; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Marie A Chisholm-Burns
Journal:  J Am Geriatr Soc       Date:  2019-01-23       Impact factor: 5.562

3.  Medicare backs off on MTM changes: congressional and patient-group opposition to other, more controversial part d reforms sank the plan.

Authors:  Stephen Barlas
Journal:  P T       Date:  2014-07

4.  Major Changes for Part D Drug Plans Scheduled for 2015: Health Plans and PBMs Would Be the Chief Beneficiaries.

Authors:  Stephen Barlas
Journal:  P T       Date:  2014-03

5.  Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Authors:  Junling Wang; Yanru Qiao; Christina A Spivey; Christine Li; Caroline Clark; Yuewen Deng; Flora Liu; Jeffrey Tillman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2016-05-26

6.  Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet.

Authors:  Yuhua Bao; Yan Tang; Julie Donohue
Journal:  JAMA Psychiatry       Date:  2015-03       Impact factor: 21.596

7.  Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.

Authors:  Degan Lu; Yanru Qiao; Karen C Johnson; Junling Wang
Journal:  J Asthma       Date:  2016-09-27       Impact factor: 2.515

8.  Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program.

Authors:  Margie E Snyder; Caitlin K Frail; Heather Jaynes; Karen S Pater; Alan J Zillich
Journal:  Pharmacotherapy       Date:  2014-07-23       Impact factor: 4.705

9.  The introduction of generic risperidone in Medicare Part D.

Authors:  Vicki Fung; Mary Price; Alisa B Busch; Mary Beth Landrum; Bruce Fireman; Andrew A Nierenberg; Joseph P Newhouse; John Hsu
Journal:  Am J Manag Care       Date:  2016-01       Impact factor: 2.229

10.  Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; JoEllen Jarrett-Jamison; Christina A Spivey; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Manag Care Spec Pharm       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.